American Heart Journal
Volume 141, Issue 6 , Pages 933-939 , June 2001

The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2

Received 24 January 2000 ,Accepted 14 June 2000.

References 

  1. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330:1724–1730
  2. Holmes DR, Bates ER, Kleiman NS, et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience: the GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:668–674
  3. Goldberg RJ, Gore JM, Alpert JS, et al.  Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991;325:1117–1122
  4. Bengtson JR, Kaplan AJ, Pieper KS, et al.  Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  5. Kennedy JW, Gensini GG, Timmis GC, et al.  Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Am J Cardiol. 1985;55:871–877
  6. Becker RC. Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock. Am Heart J. 1993;125:919–929
  7. Prewitt RM, Gu S, Garber PJ, et al.  Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 1992;20:1626–1633
  8. Prewitt RM, Gu S, Schick U, et al.  Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol. 1994;23:794–798
  9. Gurbel PA, Anderson RD, MacCord CS, et al.  Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation. 1994;89:361–365
  10. Ohman EM, George BS, White CJ, et al.  Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial: the Randomized IABP Study Group. Circulation. 1994;90:792–799
  11. Ohman EM, Califf RM, George BS, et al.  The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction: the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J. 1991;121:895–901
  12. Kono T, Morita H, Nishina T, et al.  Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996;28:876–881
  13. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest. 1994;105:997–1002
  14. Every NR, Frederick P, Robinson M, et al.  Internal validity of AMI databases: a comparison of the NRMI-2 and CCP databases. J Am Coll Cardiol. 1998;31:173A
  15. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol. 1991;18:1077–1084
  16. Mueller H, Ayres SM, Conklin EF, et al.  The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest. 1971;50:1885–1900
  17. Anderson RD, Ohman EM, Holmes DR, et al.  Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study: Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:708–715
  18. Berger PB, Holmes DR, Stebbins AL, et al.  Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an observational study. Circulation. 1997;96:122–127
  19. Hochman JS, Sleeper LA, Webb JG, et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625–634
  20. Stone GW, Marsalese D, Brodie BR, et al.  A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty: Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 1997;29:1459–1467
  21. Rogers WJ, Bowlby LJ, Chandra NC, et al.  Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103–2114

☆ Supported in part by a grant from Datascope Corp, Montiale, NJ, and Genentech Inc, South San Francisco, Calif.

☆☆ Reprint requests: Hal V. Barron, MD, 1 DNA Way, South San Francisco, CA 94080. E-mail: barron.hal@gene.com

★ The first author, Hal V. Barron, is an employee of Genentech Inc, South San Francisco, Calif.

PII: S0002-8703(01)56961-6

doi: 10.1067/mhj.2001.115295

American Heart Journal
Volume 141, Issue 6 , Pages 933-939 , June 2001

Article Tools

* Image Usage & Resolution